New Enterprise Associates related stories
All articles and analysis
- Pluribus Networks pulls in $50 mln Series D
Pluribus Networks, an SDN platform provider, has raised $50 million in Series D funding. Temasek Holdings led the round with participation from previous backers that included New Enterprise Associates, Menlo Ventures, Mohr Davidow and AME Cloud Ventures.
- Bloom Energy raises another $130 mln, report says
Bloom Energy has set out to raise another $160 million in a convertible note financing, according to The Wall Street Journal.
- BlockCypher collects over $3.1 mln seed
San Mateo, California-based BlockCypher, a block chain web services startup, has secured over $3.1 million in seed funding. The investors in the round included Foundation Capital, New Enterprise Associates, AME Cloud Ventures, Tim Draper, Upside Partnership, Streamlined Ventures and Fenox Venture Capital.
- NEA promotes three, including two to partner
New Enterprise Associates, which is planning to raise $2.5 billion for its 15th fund, announced that Frank Torti that Rick Yang have each been promoted to partner, while Aaron Jacobson was named a principal. Torti joined the firm in 2007 and has focused on healthcare, particularly biopharma and medical devices. Yang also joined in 2007 and focuses on the IT space and fintech. Jacobson, who has been with NEA since 2011, focuses on IT and energy technology.
- NEA sets sights on $2.5 bln 15th fund
New Enterprise Associates announced in a filing that is has begun raising a $2.5 billion 15th fund, according to the document submitted to the Securities and Exchange Commission. A first close has not yet taken place, the documents states.
- Cortendo to raise up to $27.5 mln in private placement
Cortendo AB has agreed to receive up to $27.5 million in a private placement. The investors are RA Capital Management, New Enterprise Associates, Broadfin Capital and HealthCap. Headquartered in Göteborg, Sweden and with offices in Radnor, Pennsylvania, Cortendo is a biopharmaceutical firm focused on orphan endocrine disorders.
- MongoDB grabs $80 mln
Data management firm MongoDB has raised $80 million in funding. The investors included Goldman Sachs, Altimeter Capital, NEA, Sequoia and T. Rowe Price Associates.
- Welltok scores $37 mln Series D
Denver-based health optimization firm Welltok has closed its Series D funding round at $37 million. Bessemer Venture Partners led the round with participation from other investors that included Hearst Health Ventures, Catholic Health Initiatives, Emergence Capital Partners, InterWest Partners, New Enterprise Associates and Qualcomm Ventures.
- NEA leads Series A round for Vtesse
Gaithersburg, Maryland-based Vtesse, a drug developer for Niemann-Pick Disease Type C, has received $25 million in Series A funding. New Enterprise Associates led the round with participation from Pfizer Venture Investments, Lundbeckfond Ventures, Bay City Capital and Alexandria Venture Investments.
- Surface Oncology attracts $35 mln Series A
Surface Oncology has secured $35 million in Series A funding. Atlas Venture, Fidelity Biosciences, Lilly Ventures and New Enterprise Associates led the round with participation from other investors that included Amgen Ventures and Novartis Institute for Biomedical Research. In addition to the funding, Dr. Elliott Sigal, former head of R&D at Bristol Myers Squibb, has been added to the company’s scientific advisory board. Based in Cambridge, Mass., Surface Oncology is a developer of next-generation cancer immunotherapies.